POS-534 TRAJECTORIES OF CLINICAL AND LABORATORY CHARACTERISTICS ASSOCIATED WITH COVID-19 IN HEMODIALYSIS PATIENTS BY SURVIVAL

• R. Lasky,
• S. Chaudhuri,
• Y. Jiao,
• J. Larkin MS,
• C. Monaghan,
• A. Winter,
• J. Raimann,
• L. Neri,
• P. Kotanko,
• J. Hymes,
• S. Lee,
• L. Usvyat,
• J. Kooman,
• F. Maddux

Affiliations

R. Lasky

Fresenius Medical Care- Global Medical Office, Applied Advanced Analytics, Waltham, United States

S. Chaudhuri

Fresenius Medical Care- Global Medical Office, Applied Advanced Analytics, Waltham, United States

Y. Jiao

Fresenius Medical Care- Global Medical Office, Applied Advanced Analytics, Waltham, United States

J. Larkin MS

Fresenius Medical Care- Global Medical Office, Applied Advanced Analytics, Waltham, United States

C. Monaghan

Fresenius Medical Care- Global Medical Office, Applied Advanced Analytics, Waltham, United States

A. Winter

Fresenius Medical Care Deutschland GmbH- EMEA Medical Office, Clinical & Epidemiological Research, Bad Homburg, Germany

J. Raimann

Renal Research Institute, Research Division, New York, United States

L. Neri

Fresenius Medical Care Deutschland GmbH, Clinical & Data Intelligence Systems - Advanced Analytics, Bad Homburg, Germany

P. Kotanko

Renal Research Institute, Research Division, New York, United States; Icahn School of Medicine at Mount Sinai, Nephrology, New York, United States

J. Hymes

Fresenius Medical Care North America, Medical Office, Waltham, United States

S. Lee

Kyung Hee University Hospital at Gangdong, Department of Nephrology, Seoul, Korea- Republic Of

L. Usvyat

Fresenius Medical Care- Global Medical Office, Applied Advanced Analytics, Waltham, United States

J. Kooman

Maastricht University, Department of Internal Medicine- Division of Nephrology, Maastricht, Netherlands

F. Maddux

Fresenius Medical Care AG & Co. KGaA, Global Medical Office, Bad Homburg, Germany